APO Research
Talk to an analyst

APO RESEARCH · REPORT

Rifaximin

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Rifaximin Market Analysis and Forecast 2026-2032

22 December 2025193 pages

Choose your research edition.

Industry ResearchRifaximin Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Rifaximin Industry Growth and Trends Forecast to 203293 pages · $3,450 USDMarket StructureGlobal Rifaximin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Rifaximin Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Rifaximin Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Rifaximin market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Rifaximin is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Rifaximin is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Rifaximin is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Rifaximin is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Rifaximin include Texas Pharmaceuticals, STERIS PHARMA, Soigner Pharma, Salix Pharmaceuticals and Cassopeia Pharmaceuticals, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Rifaximin, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Rifaximin, also provides the sales of main regions and countries. Of the upcoming market potential for Rifaximin, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Rifaximin sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Rifaximin market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Rifaximin sales, projected growth trends, production technology, application and end-user industry.

Rifaximin Segment by Company

Texas Pharmaceuticals

STERIS PHARMA

Soigner Pharma

Salix Pharmaceuticals

Cassopeia Pharmaceuticals

Rifaximin Segment by Type

200 mg Tablets

550 mg Tablets

Rifaximin Segment by Application

Hospital

Drug store

Rifaximin Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Rifaximin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Rifaximin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Rifaximin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Rifaximin in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Rifaximin manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Rifaximin sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Rifaximin Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 200 mg Tablets Major Manufacturers Table 3. 550 mg Tablets Major Manufacturers Table 4. Global Rifaximin Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital Major Manufacturers Table 6. Drug store Major Manufacturers Table 7. Rifaximin Industry Trends Table 8. Rifaximin Industry Drivers Table 9. Rifaximin Industry Opportunities and Challenges Table 10. Rifaximin Industry Restraints Table 11. Global Rifaximin Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 12. Global Rifaximin Revenue by Region (2021-2026) & (US$ Million) Table 13. Global Rifaximin Revenue by Region (2027-2032) & (US$ Million) Table 14. Global Rifaximin Revenue Market Share by Region (2021-2026) Table 15. Global Rifaximin Revenue Market Share by Region (2027-2032) Table 16. Global Rifaximin Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 17. Global Rifaximin Sales by Region (2021-2026) & (k units) Table 18. Global Rifaximin Sales by Region (2027-2032) & (k units) Table 19. Global Rifaximin Sales Market Share by Region (2021-2026) Table 20. Global Rifaximin Sales Market Share by Region (2027-2032) Table 21. Global Rifaximin Revenue by Manufacturers (US$ Million) & (2021-2026) Table 22. Global Rifaximin Revenue Market Share by Manufacturers (2021-2026) Table 23. Global Rifaximin Sales by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Rifaximin Sales Market Share by Manufacturers (2021-2026) Table 25. Global Rifaximin Sales Price (US$/unit) of Manufacturers (2021-2026) Table 26. Global Rifaximin Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 27. Global Rifaximin Key Manufacturers Manufacturing Sites & Headquarters Table 28. Global Rifaximin Manufacturers, Product Type & Application Table 29. Global Rifaximin Manufacturers' Establishment Date Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global Rifaximin by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 32. Global Rifaximin Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Rifaximin Revenue by Type (2021-2026) & (US$ Million) Table 34. Global Rifaximin Revenue by Type (2027-2032) & (US$ Million) Table 35. Global Rifaximin Revenue Market Share by Type (2021-2026) Table 36. Global Rifaximin Revenue Market Share by Type (2027-2032) Table 37. Global Rifaximin Sales by Type 2021 VS 2025 VS 2032 (k units) Table 38. Global Rifaximin Sales by Type (2021-2026) & (k units) Table 39. Global Rifaximin Sales by Type (2027-2032) & (k units) Table 40. Global Rifaximin Sales Market Share by Type (2021-2026) Table 41. Global Rifaximin Sales Market Share by Type (2027-2032) Table 42. Global Rifaximin Price by Type (2021-2026) & (US$/unit) Table 43. Global Rifaximin Price by Type (2027-2032) & (US$/unit) Table 44. Global Rifaximin Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global Rifaximin Revenue by Application (2021-2026) & (US$ Million) Table 46. Global Rifaximin Revenue by Application (2027-2032) & (US$ Million) Table 47. Global Rifaximin Revenue Market Share by Application (2021-2026) Table 48. Global Rifaximin Revenue Market Share by Application (2027-2032) Table 49. Global Rifaximin Sales by Application 2021 VS 2025 VS 2032 (k units) Table 50. Global Rifaximin Sales by Application (2021-2026) & (k units) Table 51. Global Rifaximin Sales by Application (2027-2032) & (k units) Table 52. Global Rifaximin Sales Market Share by Application (2021-2026) Table 53. Global Rifaximin Sales Market Share by Application (2027-2032) Table 54. Global Rifaximin Price by Application (2021-2026) & (US$/unit) Table 55. Global Rifaximin Price by Application (2027-2032) & (US$/unit) Table 56. Texas Pharmaceuticals Company Information Table 57. Texas Pharmaceuticals Business Overview Table 58. Texas Pharmaceuticals Rifaximin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 59. Texas Pharmaceuticals Rifaximin Product Portfolio Table 60. Texas Pharmaceuticals Recent Development Table 61. STERIS PHARMA Company Information Table 62. STERIS PHARMA Business Overview Table 63. STERIS PHARMA Rifaximin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 64. STERIS PHARMA Rifaximin Product Portfolio Table 65. STERIS PHARMA Recent Development Table 66. Soigner Pharma Company Information Table 67. Soigner Pharma Business Overview Table 68. Soigner Pharma Rifaximin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 69. Soigner Pharma Rifaximin Product Portfolio Table 70. Soigner Pharma Recent Development Table 71. Salix Pharmaceuticals Company Information Table 72. Salix Pharmaceuticals Business Overview Table 73. Salix Pharmaceuticals Rifaximin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Salix Pharmaceuticals Rifaximin Product Portfolio Table 75. Salix Pharmaceuticals Recent Development Table 76. Cassopeia Pharmaceuticals Company Information Table 77. Cassopeia Pharmaceuticals Business Overview Table 78. Cassopeia Pharmaceuticals Rifaximin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Cassopeia Pharmaceuticals Rifaximin Product Portfolio Table 80. Cassopeia Pharmaceuticals Recent Development Table 81. North America Rifaximin Revenue by Type (2021-2026) & (US$ Million) Table 82. North America Rifaximin Revenue by Type (2027-2032) & (US$ Million) Table 83. North America Rifaximin Sales by Type (2021-2026) & (k units) Table 84. North America Rifaximin Sales by Type (2027-2032) & (k units) Table 85. North America Rifaximin Sales Price by Type (2021-2026) & (US$/unit) Table 86. North America Rifaximin Sales Price by Type (2027-2032) & (US$/unit) Table 87. North America Rifaximin Revenue by Application (2021-2026) & (US$ Million) Table 88. North America Rifaximin Revenue by Application (2027-2032) & (US$ Million) Table 89. North America Rifaximin Sales by Application (2021-2026) & (k units) Table 90. North America Rifaximin Sales by Application (2027-2032) & (k units) Table 91. North America Rifaximin Sales Price by Application (2021-2026) & (US$/unit) Table 92. North America Rifaximin Sales Price by Application (2027-2032) & (US$/unit) Table 93. North America Rifaximin Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 94. North America Rifaximin Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 95. North America Rifaximin Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 96. North America Rifaximin Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 97. North America Rifaximin Sales by Country (2021-2026) & (k units) Table 98. North America Rifaximin Sales by Country (2027-2032) & (k units) Table 99. North America Rifaximin Sales Price by Country (2021-2026) & (US$/unit) Table 100. North America Rifaximin Sales Price by Country (2027-2032) & (US$/unit) Table 101. United States Rifaximin Revenue (2021-2032) & (US$ Million) Table 102. Canada Rifaximin Revenue (2021-2032) & (US$ Million) Table 103. Mexico Rifaximin Revenue (2021-2032) & (US$ Million) Table 104. Europe Rifaximin Revenue by Type (2021-2026) & (US$ Million) Table 105. Europe Rifaximin Revenue by Type (2027-2032) & (US$ Million) Table 106. Europe Rifaximin Sales by Type (2021-2026) & (k units) Table 107. Europe Rifaximin Sales by Type (2027-2032) & (k units) Table 108. Europe Rifaximin Sales Price by Type (2021-2026) & (US$/unit) Table 109. Europe Rifaximin Sales Price by Type (2027-2032) & (US$/unit) Table 110. Europe Rifaximin Revenue by Application (2021-2026) & (US$ Million) Table 111. Europe Rifaximin Revenue by Application (2027-2032) & (US$ Million) Table 112. Europe Rifaximin Sales by Application (2021-2026) & (k units) Table 113. Europe Rifaximin Sales by Application (2027-2032) & (k units) Table 114. Europe Rifaximin Sales Price by Application (2021-2026) & (US$/unit) Table 115. Europe Rifaximin Sales Price by Application (2027-2032) & (US$/unit) Table 116. Europe Rifaximin Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 117. Europe Rifaximin Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 118. Europe Rifaximin Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 119. Europe Rifaximin Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 120. Europe Rifaximin Sales by Country (2021-2026) & (k units) Table 121. Europe Rifaximin Sales by Country (2027-2032) & (k units) Table 122. Europe Rifaximin Sales Price by Country (2021-2026) & (US$/unit) Table 123. Europe Rifaximin Sales Price by Country (2027-2032) & (US$/unit) Table 124. Germany Rifaximin Revenue (2021-2032) & (US$ Million) Table 125. France Rifaximin Revenue (2021-2032) & (US$ Million) Table 126. U.K. Rifaximin Revenue (2021-2032) & (US$ Million) Table 127. Italy Rifaximin Revenue (2021-2032) & (US$ Million) Table 128. Russia Rifaximin Revenue (2021-2032) & (US$ Million) Table 129. Spain Rifaximin Revenue (2021-2032) & (US$ Million) Table 130. Netherlands Rifaximin Revenue (2021-2032) & (US$ Million) Table 131. Switzerland Rifaximin Revenue (2021-2032) & (US$ Million) Table 132. Sweden Rifaximin Revenue (2021-2032) & (US$ Million) Table 133. Poland Rifaximin Revenue (2021-2032) & (US$ Million) Table 134. China Rifaximin Revenue by Type (2021-2026) & (US$ Million) Table 135. China Rifaximin Revenue by Type (2027-2032) & (US$ Million) Table 136. China Rifaximin Sales by Type (2021-2026) & (k units) Table 137. China Rifaximin Sales by Type (2027-2032) & (k units) Table 138. China Rifaximin Sales Price by Type (2021-2026) & (US$/unit) Table 139. China Rifaximin Sales Price by Type (2027-2032) & (US$/unit) Table 140. China Rifaximin Revenue by Application (2021-2026) & (US$ Million) Table 141. China Rifaximin Revenue by Application (2027-2032) & (US$ Million) Table 142. China Rifaximin Sales by Application (2021-2026) & (k units) Table 143. China Rifaximin Sales by Application (2027-2032) & (k units) Table 144. China Rifaximin Sales Price by Application (2021-2026) & (US$/unit) Table 145. China Rifaximin Sales Price by Application (2027-2032) & (US$/unit) Table 146. Asia Rifaximin Revenue by Type (2021-2026) & (US$ Million) Table 147. Asia Rifaximin Revenue by Type (2027-2032) & (US$ Million) Table 148. Asia Rifaximin Sales by Type (2021-2026) & (k units) Table 149. Asia Rifaximin Sales by Type (2027-2032) & (k units) Table 150. Asia Rifaximin Sales Price by Type (2021-2026) & (US$/unit) Table 151. Asia Rifaximin Sales Price by Type (2027-2032) & (US$/unit) Table 152. Asia Rifaximin Revenue by Application (2021-2026) & (US$ Million) Table 153. Asia Rifaximin Revenue by Application (2027-2032) & (US$ Million) Table 154. Asia Rifaximin Sales by Application (2021-2026) & (k units) Table 155. Asia Rifaximin Sales by Application (2027-2032) & (k units) Table 156. Asia Rifaximin Sales Price by Application (2021-2026) & (US$/unit) Table 157. Asia Rifaximin Sales Price by Application (2027-2032) & (US$/unit) Table 158. Asia Rifaximin Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 159. Asia Rifaximin Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 160. Asia Rifaximin Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 161. Asia Rifaximin Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 162. Asia Rifaximin Sales by Country (2021-2026) & (k units) Table 163. Asia Rifaximin Sales by Country (2027-2032) & (k units) Table 164. Asia Rifaximin Sales Price by Country (2021-2026) & (US$/unit) Table 165. Asia Rifaximin Sales Price by Country (2027-2032) & (US$/unit) Table 166. Japan Rifaximin Revenue (2021-2032) & (US$ Million) Table 167. South Korea Rifaximin Revenue (2021-2032) & (US$ Million) Table 168. India Rifaximin Revenue (2021-2032) & (US$ Million) Table 169. Australia Rifaximin Revenue (2021-2032) & (US$ Million) Table 170. Taiwan Rifaximin Revenue (2021-2032) & (US$ Million) Table 171. Southeast Asia Rifaximin Revenue (2021-2032) & (US$ Million) Table 172. SAMEA Rifaximin Revenue by Type (2021-2026) & (US$ Million) Table 173. SAMEA Rifaximin Revenue by Type (2027-2032) & (US$ Million) Table 174. SAMEA Rifaximin Sales by Type (2021-2026) & (k units) Table 175. SAMEA Rifaximin Sales by Type (2027-2032) & (k units) Table 176. SAMEA Rifaximin Sales Price by Type (2021-2026) & (US$/unit) Table 177. SAMEA Rifaximin Sales Price by Type (2027-2032) & (US$/unit) Table 178. SAMEA Rifaximin Revenue by Application (2021-2026) & (US$ Million) Table 179. SAMEA Rifaximin Revenue by Application (2027-2032) & (US$ Million) Table 180. SAMEA Rifaximin Sales by Application (2021-2026) & (k units) Table 181. SAMEA Rifaximin Sales by Application (2027-2032) & (k units) Table 182. SAMEA Rifaximin Sales Price by Application (2021-2026) & (US$/unit) Table 183. SAMEA Rifaximin Sales Price by Application (2027-2032) & (US$/unit) Table 184. SAMEA Rifaximin Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 185. SAMEA Rifaximin Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 186. SAMEA Rifaximin Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 187. SAMEA Rifaximin Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 188. SAMEA Rifaximin Sales by Country (2021-2026) & (k units) Table 189. SAMEA Rifaximin Sales by Country (2027-2032) & (k units) Table 190. SAMEA Rifaximin Sales Price by Country (2021-2026) & (US$/unit) Table 191. SAMEA Rifaximin Sales Price by Country (2027-2032) & (US$/unit) Table 192. Brazil Rifaximin Revenue (2021-2032) & (US$ Million) Table 193. Argentina Rifaximin Revenue (2021-2032) & (US$ Million) Table 194. Chile Rifaximin Revenue (2021-2032) & (US$ Million) Table 195. Colombia Rifaximin Revenue (2021-2032) & (US$ Million) Table 196. Peru Rifaximin Revenue (2021-2032) & (US$ Million) Table 197. Saudi Arabia Rifaximin Revenue (2021-2032) & (US$ Million) Table 198. Israel Rifaximin Revenue (2021-2032) & (US$ Million) Table 199. UAE Rifaximin Revenue (2021-2032) & (US$ Million) Table 200. Turkey Rifaximin Revenue (2021-2032) & (US$ Million) Table 201. Iran Rifaximin Revenue (2021-2032) & (US$ Million) Table 202. Egypt Rifaximin Revenue (2021-2032) & (US$ Million) Table 203. Key Raw Materials Table 204. Raw Materials Key Suppliers Table 205. Rifaximin Distributors List Table 206. Rifaximin Customers List Table 207. Research Programs/Design for This Report Table 208. Authors List of This Report Table 209. Secondary Sources Table 210. Primary Sources List of Figures Figure 1. Rifaximin Image Figure 2. Global Rifaximin Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Rifaximin Market Size Share 2021 VS 2025 VS 2032 Figure 4. 200 mg Tablets Image Figure 5. 550 mg Tablets Image Figure 6. Global Rifaximin Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Rifaximin Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital Image Figure 9. Drug store Image Figure 10. Global Rifaximin Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Rifaximin Revenue (2021-2032) & (US$ Million) Figure 12. Global Rifaximin Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 13. Global Rifaximin Revenue Market Share by Region: 2025 Versus 2032 Figure 14. Global Rifaximin Revenue Market Share by Region (2021-2032) Figure 15. Global Rifaximin Sales (2021-2032) & (k units) Figure 16. Global Rifaximin Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 17. Global Rifaximin Sales Market Share by Region (2021-2032) Figure 18. US & Canada & Mexico Rifaximin Sales YoY (2021-2032) & (k units) Figure 19. Europe Rifaximin Sales YoY (2021-2032) & (k units) Figure 20. China Rifaximin Sales YoY (2021-2032) & (k units) Figure 21. Asia (Excluding China) Rifaximin Sales YoY (2021-2032) & (k units) Figure 22. South America, Middle East and Africa Rifaximin Sales YoY (2021-2032) & (k units) Figure 23. Global Rifaximin Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 24. Global Rifaximin Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 26. Global Rifaximin Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Rifaximin Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 28. Global Rifaximin Revenue Market Share by Type (2021-2032) Figure 29. Global Rifaximin Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 30. Global Rifaximin Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Rifaximin Sales Market Share by Type (2021-2032) Figure 32. Global Rifaximin Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Rifaximin Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 34. Global Rifaximin Revenue Market Share by Application (2021-2032) Figure 35. Global Rifaximin Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 36. Global Rifaximin Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Rifaximin Sales Market Share by Application (2021-2032) Figure 38. North America Rifaximin Revenue Share by Type (2021-2032) Figure 39. North America Rifaximin Sales Share by Type (2021-2032) Figure 40. North America Rifaximin Revenue Share by Application (2021-2032) Figure 41. North America Rifaximin Sales Share by Application (2021-2032) Figure 42. North America Rifaximin Revenue Share by Country (2021-2032) Figure 43. North America Rifaximin Sales Share by Country (2021-2032) Figure 44. Europe Rifaximin Revenue Share by Type (2021-2032) Figure 45. Europe Rifaximin Sales Share by Type (2021-2032) Figure 46. Europe Rifaximin Revenue Share by Application (2021-2032) Figure 47. Europe Rifaximin Sales Share by Application (2021-2032) Figure 48. Europe Rifaximin Revenue Share by Country (2021-2032) Figure 49. Europe Rifaximin Sales Share by Country (2021-2032) Figure 50. China Rifaximin Revenue Share by Type (2021-2032) Figure 51. China Rifaximin Sales Share by Type (2021-2032) Figure 52. China Rifaximin Revenue Share by Application (2021-2032) Figure 53. China Rifaximin Sales Share by Application (2021-2032) Figure 54. Asia Rifaximin Revenue Share by Type (2021-2032) Figure 55. Asia Rifaximin Sales Share by Type (2021-2032) Figure 56. Asia Rifaximin Revenue Share by Application (2021-2032) Figure 57. Asia Rifaximin Sales Share by Application (2021-2032) Figure 58. Asia Rifaximin Revenue Share by Country (2021-2032) Figure 59. Asia Rifaximin Sales Share by Country (2021-2032) Figure 60. SAMEA Rifaximin Revenue Share by Type (2021-2032) Figure 61. SAMEA Rifaximin Sales Share by Type (2021-2032) Figure 62. SAMEA Rifaximin Revenue Share by Application (2021-2032) Figure 63. SAMEA Rifaximin Sales Share by Application (2021-2032) Figure 64. SAMEA Rifaximin Revenue Share by Country (2021-2032) Figure 65. SAMEA Rifaximin Sales Share by Country (2021-2032) Figure 66. Rifaximin Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Rifaximin Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • 200 mg Tablets
  • 550 mg Tablets
Applications
  • Hospital
  • Drug store
Companies covered
  • Texas Pharmaceuticals
  • STERIS PHARMA
  • Soigner Pharma
  • Salix Pharmaceuticals
  • Cassopeia Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Rifaximin Market by Type
  3. 1.2.1 Global Rifaximin Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 200 mg Tablets
  5. 1.2.3 550 mg Tablets
  6. 1.3 Rifaximin Market by Application
  7. 1.3.1 Global Rifaximin Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital
  9. 1.3.3 Drug store
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Rifaximin Market Dynamics
  1. 2.1 Rifaximin Industry Trends
  2. 2.2 Rifaximin Industry Drivers
  3. 2.3 Rifaximin Industry Opportunities and Challenges
  4. 2.4 Rifaximin Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Rifaximin Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Rifaximin Revenue by Region
  3. 3.2.1 Global Rifaximin Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Rifaximin Revenue by Region (2021-2026)
  5. 3.2.3 Global Rifaximin Revenue by Region (2027-2032)
  6. 3.2.4 Global Rifaximin Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Rifaximin Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Rifaximin Sales by Region
  9. 3.4.1 Global Rifaximin Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Rifaximin Sales by Region (2021-2026)
  11. 3.4.3 Global Rifaximin Sales by Region (2027-2032)
  12. 3.4.4 Global Rifaximin Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Rifaximin Revenue by Manufacturers
  2. 4.1.1 Global Rifaximin Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Rifaximin Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Rifaximin Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Rifaximin Sales by Manufacturers
  6. 4.2.1 Global Rifaximin Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Rifaximin Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Rifaximin Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Rifaximin Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Rifaximin Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Rifaximin Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Rifaximin Manufacturers, Product Type & Application
  13. 4.7 Global Rifaximin Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Rifaximin Market CR5 and HHI
  16. 4.8.2 2025 Rifaximin Tier 1, Tier 2, and Tier 3
5 Rifaximin Market by Type
  1. 5.1 Global Rifaximin Revenue by Type
  2. 5.1.1 Global Rifaximin Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Rifaximin Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Rifaximin Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Rifaximin Sales by Type
  6. 5.2.1 Global Rifaximin Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Rifaximin Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Rifaximin Sales Market Share by Type (2021-2032)
  9. 5.3 Global Rifaximin Price by Type
6 Rifaximin Market by Application
  1. 6.1 Global Rifaximin Revenue by Application
  2. 6.1.1 Global Rifaximin Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Rifaximin Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Rifaximin Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Rifaximin Sales by Application
  6. 6.2.1 Global Rifaximin Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Rifaximin Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Rifaximin Sales Market Share by Application (2021-2032)
  9. 6.3 Global Rifaximin Price by Application
7 Company Profiles
  1. 7.1 Texas Pharmaceuticals
  2. 7.1.1 Texas Pharmaceuticals Company Information
  3. 7.1.2 Texas Pharmaceuticals Business Overview
  4. 7.1.3 Texas Pharmaceuticals Rifaximin Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Texas Pharmaceuticals Rifaximin Product Portfolio
  6. 7.1.5 Texas Pharmaceuticals Recent Developments
  7. 7.2 STERIS PHARMA
  8. 7.2.1 STERIS PHARMA Company Information
  9. 7.2.2 STERIS PHARMA Business Overview
  10. 7.2.3 STERIS PHARMA Rifaximin Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 STERIS PHARMA Rifaximin Product Portfolio
  12. 7.2.5 STERIS PHARMA Recent Developments
  13. 7.3 Soigner Pharma
  14. 7.3.1 Soigner Pharma Company Information
  15. 7.3.2 Soigner Pharma Business Overview
  16. 7.3.3 Soigner Pharma Rifaximin Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Soigner Pharma Rifaximin Product Portfolio
  18. 7.3.5 Soigner Pharma Recent Developments
  19. 7.4 Salix Pharmaceuticals
  20. 7.4.1 Salix Pharmaceuticals Company Information
  21. 7.4.2 Salix Pharmaceuticals Business Overview
  22. 7.4.3 Salix Pharmaceuticals Rifaximin Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Salix Pharmaceuticals Rifaximin Product Portfolio
  24. 7.4.5 Salix Pharmaceuticals Recent Developments
  25. 7.5 Cassopeia Pharmaceuticals
  26. 7.5.1 Cassopeia Pharmaceuticals Company Information
  27. 7.5.2 Cassopeia Pharmaceuticals Business Overview
  28. 7.5.3 Cassopeia Pharmaceuticals Rifaximin Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Cassopeia Pharmaceuticals Rifaximin Product Portfolio
  30. 7.5.5 Cassopeia Pharmaceuticals Recent Developments
8 North America
  1. 8.1 North America Rifaximin Market Size by Type
  2. 8.1.1 North America Rifaximin Revenue by Type (2021-2032)
  3. 8.1.2 North America Rifaximin Sales by Type (2021-2032)
  4. 8.1.3 North America Rifaximin Price by Type (2021-2032)
  5. 8.2 North America Rifaximin Market Size by Application
  6. 8.2.1 North America Rifaximin Revenue by Application (2021-2032)
  7. 8.2.2 North America Rifaximin Sales by Application (2021-2032)
  8. 8.2.3 North America Rifaximin Price by Application (2021-2032)
  9. 8.3 North America Rifaximin Market Size by Country
  10. 8.3.1 North America Rifaximin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Rifaximin Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Rifaximin Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Rifaximin Market Size by Type
  2. 9.1.1 Europe Rifaximin Revenue by Type (2021-2032)
  3. 9.1.2 Europe Rifaximin Sales by Type (2021-2032)
  4. 9.1.3 Europe Rifaximin Price by Type (2021-2032)
  5. 9.2 Europe Rifaximin Market Size by Application
  6. 9.2.1 Europe Rifaximin Revenue by Application (2021-2032)
  7. 9.2.2 Europe Rifaximin Sales by Application (2021-2032)
  8. 9.2.3 Europe Rifaximin Price by Application (2021-2032)
  9. 9.3 Europe Rifaximin Market Size by Country
  10. 9.3.1 Europe Rifaximin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Rifaximin Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Rifaximin Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Rifaximin Market Size by Type
  2. 10.1.1 China Rifaximin Revenue by Type (2021-2032)
  3. 10.1.2 China Rifaximin Sales by Type (2021-2032)
  4. 10.1.3 China Rifaximin Price by Type (2021-2032)
  5. 10.2 China Rifaximin Market Size by Application
  6. 10.2.1 China Rifaximin Revenue by Application (2021-2032)
  7. 10.2.2 China Rifaximin Sales by Application (2021-2032)
  8. 10.2.3 China Rifaximin Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Rifaximin Market Size by Type
  2. 11.1.1 Asia Rifaximin Revenue by Type (2021-2032)
  3. 11.1.2 Asia Rifaximin Sales by Type (2021-2032)
  4. 11.1.3 Asia Rifaximin Price by Type (2021-2032)
  5. 11.2 Asia Rifaximin Market Size by Application
  6. 11.2.1 Asia Rifaximin Revenue by Application (2021-2032)
  7. 11.2.2 Asia Rifaximin Sales by Application (2021-2032)
  8. 11.2.3 Asia Rifaximin Price by Application (2021-2032)
  9. 11.3 Asia Rifaximin Market Size by Country
  10. 11.3.1 Asia Rifaximin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Rifaximin Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Rifaximin Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Rifaximin Market Size by Type
  2. 12.1.1 SAMEA Rifaximin Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Rifaximin Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Rifaximin Price by Type (2021-2032)
  5. 12.2 SAMEA Rifaximin Market Size by Application
  6. 12.2.1 SAMEA Rifaximin Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Rifaximin Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Rifaximin Price by Application (2021-2032)
  9. 12.3 SAMEA Rifaximin Market Size by Country
  10. 12.3.1 SAMEA Rifaximin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Rifaximin Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Rifaximin Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Rifaximin Value Chain Analysis
  2. 13.1.1 Rifaximin Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Rifaximin Production Mode & Process
  6. 13.2 Rifaximin Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Rifaximin Distributors
  9. 13.2.3 Rifaximin Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst